Document Preview Unavailable

The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

Pan, Min; Wright, William C; Chapple, Rich; Zubair, Asif; Sandhu, Manbir; et al.  bioRxiv, Feb 25, 2021.

You might have access to this document